Clinical trials, drug development and research news
Tag
Drug ApprovalsThe MHRA has extended Casgevy to children from age five with severe sickle cell disease or thalassaemia, and NICE has widened NHS managed access to match.
30 October 2026
Industry & RegulationSix months into the UK's new clinical trial regulations, the MHRA reports seven-day average approvals for low-risk changes and lists the mistakes that still delay applications.
28 October 2026
Drug ApprovalsThe MHRA has approved Icotyde for moderate to severe plaque psoriasis from age 12, after trials in which it beat placebo and an existing oral psoriasis pill.
23 October 2026
Industry & RegulationThe UK regulator's five-year plan sets guaranteed assessment times backed by fee rebates, an AI protocol checker and a goal of third place globally for phase 1 trials.
14 October 2026
Drug ApprovalsThe MHRA has authorised Onswik, a basal insulin injected once a week, and NICE has backed it for NHS use, mainly to cut time spent helping people inject.
13 October 2026
Patient GuidesApproved does not always mean available. This guide explains how the FDA, MHRA and EMA review medicines, how NICE decides NHS funding, and why countries differ.
8 October 2026